The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples